Literature DB >> 6698971

Adenine nucleotide stimulation of Ca2+-induced Ca2+ release in sarcoplasmic reticulum.

G Meissner.   

Abstract

Rabbit skeletal muscle sarcoplasmic reticulum was fractionated into a "Ca2+-release" and "control" fraction by differential and sucrose gradient centrifugation. External Ca2+ (2-20 microM) caused the release of 40 nmol of 45Ca2+/mg of protein/s from Ca2+-release vesicles passively loaded at pH 6.8 with an internal half-saturation Ca2+ concentration of 10-20 mM. Ca2+-induced Ca2+ release had an approximate pK value of 6.6 and was half-maximally inhibited at an external Ca2+ concentration of 2 X 10(-4) M and Mg2+ concentration of 7 X 10(-5) M. 45Ca2+ efflux from control vesicles was slightly inhibited at external Ca2+ concentrations that stimulated the rapid release of Ca2+ from Ca2+-release vesicles. Adenine, adenosine, and derived nucleotides caused stimulation of Ca2+-induced Ca2+ release in media containing a "physiological" free Mg2+ concentration of 0.6 mM. At a concentration of 1 mM, the order of effectiveness was AMP-PCP greater than cAMP approximately AMP approximately ADP greater than adenine greater than adenosine. Other nucleoside triphosphates and caffeine were minimally effective in increasing 45Ca2+ efflux from passively loaded Ca2+-release vesicles. La3+, ruthenium red, and procaine inhibited Ca2+-induced Ca2+ release. Ca2+ flux studies with actively loaded vesicles also indicated that a subpopulation of sarcoplasmic reticulum vesicles contains a Ca2+ permeation system that is activated by adenine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698971

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  120 in total

1.  AMP is a partial agonist at the sheep cardiac ryanodine receptor.

Authors:  L L Ching; A J Williams; R Sitsapesan
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Two domains in dihydropyridine receptor activate the skeletal muscle Ca(2+) release channel.

Authors:  M Stange; A Tripathy; G Meissner
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

3.  Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).

Authors:  G G Du; H Oyamada; V K Khanna; D H MacLennan
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

Review 4.  Ion conduction and discrimination in the sarcoplasmic reticulum ryanodine receptor/calcium-release channel.

Authors:  A J Williams
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

Review 5.  Kinetic analysis of excitation-contraction coupling.

Authors:  N Ikemoto; M Ronjat; L G Mészáros
Journal:  J Bioenerg Biomembr       Date:  1989-04       Impact factor: 2.945

Review 6.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

7.  Dihydropyridine-sensitive skeletal muscle Ca channels in polarized planar bilayers. 1. Kinetics and voltage dependence of gating.

Authors:  J Ma; C Mundiña-Weilenmann; M M Hosey; E Ríos
Journal:  Biophys J       Date:  1991-10       Impact factor: 4.033

8.  Properties of Ca(2+) release induced by clofibric acid from the sarcoplasmic reticulum of mouse skeletal muscle fibres.

Authors:  T Ikemoto; M Endo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

10.  Activation and labelling of the purified skeletal muscle ryanodine receptor by an oxidized ATP analogue.

Authors:  M Hohenegger; A Herrmann-Frank; M Richter; F Lehmann-Horn
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.